Slide 28 mentions Lympro partnerships.

If fact right before, at 31:54, they said they are evaluating strategic transactions (not options). At that point you here someone gasp in the audience. I don't think they fell over as I didn't hear a follow on thud.

I won't mention that MSPrecise is targeted to have CLIA in Q4 with a 2.2B opp.